These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3464812)

  • 41. Studies on aclacinomycin A resistance in mouse lymphoblastoma.
    Nishimura T; Suzuki H; Muto K; Tanaka Y; Tanaka N
    J Antibiot (Tokyo); 1980 Jul; 33(7):737-43. PubMed ID: 6931828
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased expression of GATA-1 and NFE-2 erythroid-specific transcription factors during aclacinomycin-mediated differentiation of human erythroleukemic cells.
    Trentesaux C; Nyoung MN; Aries A; Morceau F; Ronchi A; Ottolenghi S; Jardillier JC; Jeannesson P
    Leukemia; 1993 Mar; 7(3):452-7. PubMed ID: 8445949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The antitumor effects of anthracyclines. The importance of the carbomethoxy-group at position-10 of marcellomycin and rudolfomycin.
    DuVernay VH; Essery JM; Doyle TW; Bradner WT; Crooke ST
    Mol Pharmacol; 1979 Mar; 15(2):341-56. PubMed ID: 470932
    [No Abstract]   [Full Text] [Related]  

  • 44. Antitumor activity of new anthracycline antibiotics, aclacinomycin-A and its analogs, and their toxicity.
    Hori S; Shirai M; Hirano S; Oki T; Inui T; Tsukagoshi S; Ishizuka M; Takeuchi T; Umezawa H
    Gan; 1977 Oct; 68(5):685-90. PubMed ID: 579346
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inducers of erythroid differentiation in K562 human leukemia cells.
    Rowley PT; Ohlsson-Wilhelm BM; Farley BA; LaBella S
    Exp Hematol; 1981 Jan; 9(1):32-7. PubMed ID: 6940756
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system.
    Umezawa K; Haresaku M; Muramatsu M; Matsushima T
    Biomed Pharmacother; 1987; 41(5):214-8. PubMed ID: 2444280
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Enhancement of immune responses and possible inhibition of suppressor cells by aclacinomycin A.
    Ishizuka M; Takeuchi T; Masuda T; Fukasawa S; Umezawa H
    J Antibiot (Tokyo); 1981 Mar; 34(3):331-40. PubMed ID: 6456249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Chemical modification of anthracycline antibiotics. I. Demethoxycarbonylation, 10-epimerization and 4-o-methylation of aclacinomycin A.
    Tanaka H; Yoshioka T; Shimauchi Y; Matsuzawa Y; Oki T; Inui T
    J Antibiot (Tokyo); 1980 Nov; 33(11):1323-30. PubMed ID: 6941951
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitory effects of several anthracyclines on mitochondrial respiration and coenzyme Q10 protection.
    Solaini G; Ronca G; Bertelli A
    Drugs Exp Clin Res; 1985; 11(8):533-7. PubMed ID: 3869924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Arugomycin, a new anthracycline antibiotic. III. Biological activities of arugomycin and its analogues obtained by chemical degradation and modification.
    Shimosaka A; Kawai H; Hayakawa Y; Komeshima N; Nakagawa M; Seto H; Otake N
    J Antibiot (Tokyo); 1987 Sep; 40(9):1283-91. PubMed ID: 3479414
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The 1985 Walter Hubert lecture. Malignant cell differentiation as a potential therapeutic approach.
    Sartorelli AC
    Br J Cancer; 1985 Sep; 52(3):293-302. PubMed ID: 3899154
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical studies of aclacinomycin A (ACM).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
    Oki T; Takeuchi T; Oka S; Umezawa H
    Recent Results Cancer Res; 1980; 74():207-16. PubMed ID: 7003659
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Potentiation of adriamycin accumulation and effectiveness in adriamycin-resistant cells by aclacinomycin A.
    Tapiero H; Boulé D; Trincal G; Fourcade A; Lampidis TJ
    Leuk Res; 1988; 12(5):411-8. PubMed ID: 3164087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of differentiation of murine erythroleukemia cells by aminonucleoside of puromycin and inhibition of this induction by purines and purine derivatives.
    Lacour F; Harel L; Friend C; Huynh T; Holland JG
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2740-2. PubMed ID: 6930663
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interaction of anthracycline antibiotics with biopolymers. VIII. Binding parameters of aclacinomycin A to DNA.
    Katenkamp U; Stutter E; Petri I; Gollmick FA; Berg H
    J Antibiot (Tokyo); 1983 Sep; 36(9):1222-7. PubMed ID: 6579049
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differentiation of Friend erythroleukemia cells induced by benzodiazepines.
    Wang JK; Morgan JI; Spector S
    Proc Natl Acad Sci U S A; 1984 Jun; 81(12):3770-2. PubMed ID: 6587392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance.
    Bielack SS; Kallenbach K; Looft G; Erttmann R; Winkler K
    Anticancer Res; 1995; 15(4):1279-84. PubMed ID: 7654009
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recent studies on antibiotics and small molecular immunomodulators with potential usefulness in treating lung cancer: Part I - Antitumor antibiotics and their derivatives.
    Umezawa H
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):12-8. PubMed ID: 6173340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.